Bodenrader Mark

1.1

1.1

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 20 Dec 2023

Sale

Price

55.05

Quantity 28,948 +16.3%

Value US$793,727

Comments Filing

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 2 Jun 2023

Proposed sale

Price

302.27

Quantity 40,305

Value US$761,944

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 2 Jun 2023

Planned sale

Price

51.13

Quantity 85,976 -9.6%

Value US$3,777,288

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-12-21	2023-12-20	Cerevel Therapeutics Holdings Inc (CERE)	S Sale	28,948 +16.3% 55.05 US$793,727	28,948 +16.3%	55.05	US$793,727
2023-06-05	2023-06-02	Cerevel Therapeutics Holdings Inc (CERE)	PrS Proposed sale	40,305 302.27 US$761,944	40,305	302.27	US$761,944
2023-06-05	2023-06-02	Cerevel Therapeutics Holdings Inc (CERE)	PlS Planned sale	85,976 -9.6% 51.13 US$3,777,288	85,976 -9.6%	51.13	US$3,777,288